Skip to content

State Drug Authority Suspends Bupivacaine Injection Use in Cesarean Procedures

By News Analysis India · · 1 min read

In response to a distressing episode at a Hyderabad medical centre, Rajasthan’s drug regulator issued an emergency directive to halt the administration of Bupivacaine injection for spinal anaesthesia, especially in cesarean sections. The decision, taken on the advice of anaesthesiology experts, follows documented cases of severe side‑effects—including seizures and the need for ventilatory support—in sixteen patients who received the drug. The affected lot, labelled BKP 02601, was produced by Themis Medicare Limited and had already been dispatched across the state. Authorities have confiscated 7,000 vials at the Jaipur warehouse, blocked 1,500 more from reaching pharmacies, and gathered additional samples for laboratory analysis. A recall notice has been sent to hospitals, medical colleges and distributors, demanding the return of 2,000 vials. The ban stays in place pending a full safety review by the central drug control agency.